Vanderbilt Health physicians will be among the runway models during the 7th Annual T.J. Martell Foundation Chic Awearness on Sept. 23.
Jason MacGurn and colleagues have characterized a “rheostat” that sets WNT pathway signaling in breast cancer cells.
Colorectal cancer researchers from Vanderbilt-Ingram Cancer Center (VICC) have been awarded a Specialized Program of Research Excellence grant from the National Cancer Institute (NCI).
Gene variants associated with cancer risk appear to contribute to carcinogenesis by regulating target genes that in turn promote the generation of mutations.
Combining immunotherapy and radiation therapy may be a powerful treatment approach for castration-resistant prostate cancer.
A study led by Anna Vilgelm, MD, PhD, and Ann Richmond, PhD, has identified a possible second-line treatment for melanoma patients.
Accessibility Tools